Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.

中文翻译：

---

药房福利管理者阻止处方药成本不断上涨的政策建议：美国医师学院的立场文件。

最近关于处方药价格上涨的讨论主要集中在药房福利经理（PBM），针对各种类型雇主和政府购买方的第三方中介机构，这些中介机构在医疗计划中商议药品价格，因此在确定数百万美元的医疗费用中起着至关重要的作用。美国人为药物付费。在本立场文件中，美国内科医师学院从2016年开始扩展其立场文件，提出了其他建议以提高PBM行业的透明度，并强调需要为医生和患者提供可靠，及时和相关的处方药定价信息。